Advertisement
Screener

REZOLUTE, INC. (RZLT) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

REZOLUTE, INC. Stock-Based Compensation

REZOLUTE, INC. (RZLT) reported Stock-Based Compensation of $14.46 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-24.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-09-24

  • REZOLUTE, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $4.10M, a 72.84% increase year-over-year.
  • REZOLUTE, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $4.42M, a 132.02% increase year-over-year.
  • REZOLUTE, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $3.41M, a 136.06% increase year-over-year.
  • REZOLUTE, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $2.53M, a 80.79% increase year-over-year.
  • REZOLUTE, INC. share-based payment arrangement, noncash expense for fiscal 2026 was $14.46M, a 103.06% increase from fiscal 2025.
  • REZOLUTE, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $7.12M, a 3.25% decline from fiscal 2024.
  • REZOLUTE, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $7.36M, a 1.27% increase from fiscal 2023.
  • REZOLUTE, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $7.27M, a 97.23% increase from fiscal 2022.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 3 month as first filedShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 6 month as first filedShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 9 month as first filedShare-based Payment Arrangement, Noncash Expense 12 monthShare-based Payment Arrangement, Noncash Expense 12 month as first filedShare-based Payment Arrangement, Noncash Expense 36 monthShare-based Payment Arrangement, Noncash Expense 39 monthShare-based Payment Arrangement, Noncash Expense 42 monthShare-based Payment Arrangement, Noncash Expense 45 monthShare-based Payment Arrangement, Noncash Expense 48 month
2026-06-30$4.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-24
$8.52M
derived: sum of 2 quarters · filed 2026-09-24
$11.93M
derived: sum of 3 quarters · filed 2026-09-24
$14.46M
10-K · filed 2026-09-24
2026-03-31$4.42M
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-12
$7.83M
derived: sum of 2 quarters · filed 2026-05-12
$10.36M
10-Q · filed 2026-05-12
$12.73M
derived: sum of 4 quarters · filed 2026-09-24
2025-12-31$3.41M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12
$5.94M
10-Q · filed 2026-02-12
$8.31M
derived: sum of 3 quarters · filed 2026-09-24
$10.22M
derived: sum of 4 quarters · filed 2026-09-24
2025-09-30$2.53M
10-Q · filed 2025-11-06
$4.90M
derived: sum of 2 quarters · filed 2026-09-24
$6.81M
derived: sum of 3 quarters · filed 2026-09-24
$8.25M
derived: sum of 4 quarters · filed 2026-09-24
2025-06-30$2.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-24
$4.28M
derived: sum of 2 quarters · filed 2026-09-24
$5.72M
derived: sum of 3 quarters · filed 2026-09-24
$7.12M
10-K · filed 2026-09-24
2025-03-31$1.91M
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-12
$3.35M
derived: sum of 2 quarters · filed 2026-05-12
$4.75M
10-Q · filed 2026-05-12
$6.52M
derived: sum of 4 quarters · filed 2026-05-12
2024-12-31$1.45M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12
$2.85M
10-Q · filed 2026-02-12
$4.62M
derived: sum of 3 quarters · filed 2026-02-12
$6.52M
derived: sum of 4 quarters · filed 2026-02-12
2024-09-30$1.40M
10-Q · filed 2025-11-06
$3.17M
derived: sum of 2 quarters · filed 2025-11-06
$5.07M
derived: sum of 3 quarters · filed 2025-11-06
$6.91M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30$1.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-17
$3.67M
derived: sum of 2 quarters · filed 2025-09-17
$5.51M
derived: sum of 3 quarters · filed 2025-09-17
$7.36M
10-K · filed 2025-09-17
2024-03-31$1.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-13
$3.74M
derived: sum of 2 quarters · filed 2025-05-13
$5.59M
10-Q · filed 2025-05-13
$7.39M
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31$1.84M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-12
$3.69M
10-Q · filed 2025-02-12
$5.49M
derived: sum of 3 quarters · filed 2025-02-12
$7.34M
derived: sum of 4 quarters · filed 2025-02-12
2023-09-30$1.85M
10-Q · filed 2024-11-07
$3.65M
derived: sum of 2 quarters · filed 2024-11-07
$5.51M
derived: sum of 3 quarters · filed 2024-11-07
$7.24M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30$1.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-19
$3.66M
derived: sum of 2 quarters · filed 2024-09-19
$5.39M
derived: sum of 3 quarters · filed 2024-09-19
$7.27M
10-K · filed 2024-09-19
2023-03-31$1.85M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15
$3.59M
derived: sum of 2 quarters · filed 2024-05-15
$5.46M
10-Q · filed 2024-05-15
$6.45M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31$1.73M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-13
$3.61M
10-Q · filed 2024-02-13
$4.59M
derived: sum of 3 quarters · filed 2024-02-13
$5.44M
derived: sum of 4 quarters · filed 2024-02-13
2022-09-30$1.88M
10-Q · filed 2023-11-13
$2.86M
derived: sum of 2 quarters · filed 2023-11-13
$3.71M
derived: sum of 3 quarters · filed 2023-11-13
$4.72M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$984.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-14
$1.83M
derived: sum of 2 quarters · filed 2023-09-14
$2.84M
derived: sum of 3 quarters · filed 2023-09-14
$3.69M
10-K · filed 2023-09-14
2022-03-31$850.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11
$1.86M
derived: sum of 2 quarters · filed 2023-05-11
$2.70M
10-Q · filed 2023-05-11
$4.36M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$1.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-10
$1.85M
10-Q · filed 2023-02-10
$3.51M
derived: sum of 3 quarters · filed 2023-02-10
$4.04M
derived: sum of 4 quarters · filed 2023-02-10
2021-09-30$842.00K
10-Q · filed 2022-11-09
$2.50M
derived: sum of 2 quarters · filed 2022-11-09
$3.03M
derived: sum of 3 quarters · filed 2022-11-09
$4.17M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$1.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-15
$2.19M
derived: sum of 2 quarters · filed 2022-09-15
$3.33M
derived: sum of 3 quarters · filed 2022-09-15
$3.96M
10-K · filed 2022-09-15
2021-03-31$530.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-12
$1.67M
derived: sum of 2 quarters · filed 2022-05-12
$2.31M
10-Q · filed 2022-05-12
$2.89M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$1.14M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-09
$1.77M
10-Q · filed 2022-02-09
$2.36M
derived: sum of 3 quarters · filed 2022-02-09
$3.03M
derived: sum of 4 quarters · filed 2022-02-09
2020-09-30$634.00K
10-Q · filed 2021-11-12
$1.22M
derived: sum of 2 quarters · filed 2021-11-12
$1.89M
derived: sum of 3 quarters · filed 2021-11-12
$2.56M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$583.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-15
$1.26M
derived: sum of 2 quarters · filed 2021-09-15
$1.92M
derived: sum of 3 quarters · filed 2021-09-15
$3.32M
10-K · filed 2021-09-15
2020-03-31$675.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-17
$1.34M
derived: sum of 2 quarters · filed 2021-05-17
$2.73M
10-Q · filed 2021-05-17
$2.98M
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31$665.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-10
$2.06M
10-Q · filed 2021-02-10
$2.31M
derived: sum of 3 quarters · filed 2021-02-10
$3.00M
derived: sum of 4 quarters · filed 2021-02-10
2019-09-30$1.39M
10-Q · filed 2020-11-12
$1.64M
derived: sum of 2 quarters · filed 2020-11-12
$2.34M
derived: sum of 3 quarters · filed 2020-11-12
$3.15M
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30$247.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-13
$942.00K
derived: sum of 2 quarters · filed 2020-10-13
$1.76M
derived: sum of 3 quarters · filed 2020-10-13
$2.64M
10-K · filed 2020-10-13
2019-03-31$695.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-14
$1.51M
derived: sum of 2 quarters · filed 2020-05-14
$2.39M
10-Q · filed 2020-05-14
$2.39M
10-Q · filed 2019-05-10
$3.31M
derived: sum of 4 quarters · filed 2020-05-14
2018-12-31$816.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-12
$1.69M
10-Q · filed 2020-02-12
$1.69M
10-Q · filed 2019-02-14
$2.61M
derived: sum of 3 quarters · filed 2020-02-12
$4.09M
derived: sum of 4 quarters · filed 2020-02-12
2018-09-30$878.00K
10-Q · filed 2019-11-14
$877.95K
10-Q · filed 2018-12-14
$1.80M
derived: sum of 2 quarters · filed 2019-11-14
$3.27M
derived: sum of 3 quarters · filed 2019-11-14
$4.47M
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30$919.51K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-10
$2.39M
derived: sum of 2 quarters · filed 2019-09-10
$3.59M
derived: sum of 3 quarters · filed 2019-09-10
$5.09M
10-K · filed 2019-09-10
$5.10M
10-K · filed 2018-10-15
2018-03-31$1.47M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-10
$2.67M
derived: sum of 2 quarters · filed 2019-05-10
$4.18M
10-Q · filed 2019-05-10
$6.64M
derived: sum of 4 quarters · filed 2019-05-10
2017-12-31$1.19M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-14
$2.70M
10-Q · filed 2019-02-14
$5.17M
derived: sum of 3 quarters · filed 2019-02-14
$6.58M
derived: sum of 4 quarters · filed 2019-02-14
2017-09-30$1.51M
10-Q · filed 2018-12-14
$3.98M
derived: sum of 2 quarters · filed 2018-12-14
$5.39M
derived: sum of 3 quarters · filed 2018-12-14
$6.62M
derived: sum of 4 quarters · filed 2018-12-14
2017-06-30$2.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-15
$3.88M
derived: sum of 2 quarters · filed 2018-10-15
$5.12M
derived: sum of 3 quarters · filed 2018-10-15
$6.01M
10-K · filed 2018-10-15
2017-03-31$1.41M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-15
$2.65M
derived: sum of 2 quarters · filed 2018-05-15
$3.54M
10-Q · filed 2018-05-15
$4.42M
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31$1.24M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-14
$2.13M
10-Q · filed 2018-02-14
$3.01M
derived: sum of 3 quarters · filed 2018-02-14
$3.92M
derived: sum of 4 quarters · filed 2018-02-14
2016-09-30$889.03K
10-Q · filed 2017-11-14
$1.77M
derived: sum of 2 quarters · filed 2017-11-14
$2.68M
derived: sum of 3 quarters · filed 2017-11-14
$3.67M
derived: sum of 4 quarters · filed 2017-11-14
2016-06-30$884.21K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-22
$1.80M
derived: sum of 2 quarters · filed 2017-09-22
$2.78M
derived: sum of 3 quarters · filed 2017-09-22
$3.76M
10-K · filed 2017-09-22
2016-03-31$911.63K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15
$1.90M
derived: sum of 2 quarters · filed 2017-05-15
$2.88M
10-Q · filed 2017-05-15
$3.86M
derived: sum of 4 quarters · filed 2017-05-15
2015-12-31$985.64K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-02
$1.97M
10-Q · filed 2017-02-02
$2.95M
derived: sum of 3 quarters · filed 2017-02-02
$3.66M
derived: sum of 4 quarters · filed 2017-02-02
2015-09-30$980.35K
10-Q · filed 2016-11-14
$1.96M
derived: sum of 2 quarters · filed 2016-11-14
$2.67M
derived: sum of 3 quarters · filed 2016-11-14
$3.24M
derived: sum of 4 quarters · filed 2016-11-14
2015-06-30$982.60K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28
$1.69M
derived: sum of 2 quarters · filed 2016-09-28
$2.26M
derived: sum of 3 quarters · filed 2016-09-28
$2.85M
10-K · filed 2016-09-28
2015-03-31$708.71K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-16
$1.28M
derived: sum of 2 quarters · filed 2016-05-16
$1.86M
10-Q · filed 2016-05-16
$2.45M
derived: sum of 4 quarters · filed 2016-05-16
2014-12-31$566.51K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-16
$1.16M
10-Q · filed 2016-02-16
$1.74M
derived: sum of 3 quarters · filed 2016-02-16
$1.91M
derived: sum of 4 quarters · filed 2016-02-16
2014-09-30$589.01K
10-Q · filed 2015-11-16
$1.18M
derived: sum of 2 quarters · filed 2015-11-16
$1.34M
derived: sum of 3 quarters · filed 2015-11-16
$1.51M
derived: sum of 4 quarters · filed 2015-11-16
2014-06-30$586.67K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-28
$751.16K
derived: sum of 2 quarters · filed 2015-09-28
$916.47K
derived: sum of 3 quarters · filed 2015-09-28
$1.08M
10-K · filed 2015-09-28
2014-03-31$164.48K
10-Q · filed 2014-05-14
$329.80K
derived: sum of 2 quarters · filed 2014-05-14
$495.12K
10-Q · filed 2015-05-15
$912.73K
derived: sum of 4 quarters · filed 2014-11-12
$4.18M
10-Q · filed 2014-05-14
2013-12-31$165.32K
10-Q · filed 2014-02-13
$330.64K
10-Q · filed 2015-02-17
$748.25K
derived: sum of 3 quarters · filed 2014-11-12
$4.02M
derived: sum of 4 quarters · filed 2014-11-12
$4.02M
10-Q · filed 2014-02-13
2013-09-30$165.32K
10-Q · filed 2014-11-12
$582.93K
derived: sum of 2 quarters · filed 2014-11-12
$3.85M
derived: sum of 3 quarters · filed 2014-11-12
$3.85M
derived: sum of 4 quarters · filed 2014-11-12
$3.85M
10-Q · filed 2013-11-12
2013-06-30$417.61K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-30
$3.69M
derived: sum of 2 quarters · filed 2014-09-30
$3.69M
derived: sum of 3 quarters · filed 2014-09-30
$3.69M
10-K · filed 2014-09-30
$3.69M
10-K · filed 2013-09-11
2013-03-31$3.27M
10-Q · filed 2013-05-15
$3.27M
derived: sum of 2 quarters · filed 2014-02-13
$3.27M
10-Q · filed 2014-05-14
$3.27M
10-Q · filed 2013-05-15
2012-12-31$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-13
$0.00
10-Q · filed 2014-02-13
2012-09-30$0.00
10-Q · filed 2013-11-12
2012-06-30$0.00
10-K · filed 2013-09-11
2012-03-31$0.00
10-Q · filed 2013-05-15
2011-12-31$0.00
10-K · filed 2013-09-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Vogenx, Inc. (VOGX)United States$0.355B
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ENANTA PHARMACEUTICALS INC (ENTA)United States$0.349B-6.72
Emergent BioSolutions Inc. (EBS)United States$0.347B-2.43